Abstract
THERE is increasing interest in the possibility that histamine may be a neurotransmitter in the mammalian central nervous system (CNS). Electrophysiological evidence supports the existence of histamine receptors in nervous tissue through which neuronal excitability can be regulated. For example, the firing rate of certain neurones in the brain is depressed by histamine and this depression is specifically blocked by the H2 antagonist, metiamide1. In addition, histamine influences the electrical excitability of neurones in the superior cervical ganglion2. Certain neurotransmitters may exert some of their effects in nervous tissue by stimulating the formation of cyclic AMP. It is therefore of interest that histamine raises cyclic AMP levels in brain slices3–7, as do several other putative neurotransmitters, such as noradrenaline, dopamine and 5-hydroxytryptamine (5-HT). Furthermore, a dopamine-sensitive adenylate cyclase has been found in homogenates of rat caudate nucleus and olfactory tubercle, with properties very similar to those of the dopamine receptor in mammalian brain8–10. We report here the occurrence of an adenylate cyclase which is activated by low concentrations of histamine in several regions of guinea pig brain. This histamine-sensitive adenylate cyclase has the pharmacological properties of an H2 receptor. The results indicate that the actions of histamine on H2 receptors in the CNS may be mediated through cyclic AMP.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Haas, H. L., and Bucher, U. M., Nature, 225, 634–635 (1975).
Brimble, M. J., and Wallis, D. I., Nature, 246, 156–158 (1973).
Kakiuchi, S., and Rall, T. W., Molec. Pharmac., 4, 367–388 (1968).
Schultz, J., and Daly, J. W., J. Neurochem., 21, 573–579 (1973).
Chasin, M., Mamrak, F., and Samaniego, S. G., J. Neurochem., 22, 1031–1038 (1974).
Baudry, M., Martres, M.-P., and Schwartz, J. -C., Nature, 253, 362–363 (1975).
Rogers, M., Dismukes, K., and Daly, J. W., J. Neurochem., 25, 531–534 (1975).
Kebabian, J. W., Petzold, G. L., and Greengard, P., Proc. natn. Acad. Sci. U.S.A., 69, 2145–2149 (1972).
Clement-Cormier, Y. C., Kebabian, J. W., Petzold, G. L., and Greengard, P., Proc. natn. Acad. Sci., U.S.A., 71, 1113–1117 (1974).
Iversen, L. L., Science, 188, 1084–1089 (1975).
Rodbell, M., J. biol. Chem., 250, 5826–5834 (1975).
Brown, B. L., Albano, J. D. M., Ekins, R. P., and Sghersi, A. M., Biochem. J., 121, 561–562 (1971).
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., J. biol. Chem., 193, 265–275 (1951).
Clark, R. B., and Perkins, J. P., Proc. natn. Acad. Sci. U.S.A., 68, 2757–2760 (1971).
Ash, A. S. F., and Schild, H. O., Br. J. Pharmac. exp. Chemother., 27, 427–439 (1966).
Black, J. W., Duncan, W. A. M., Durant, G. J., Ganellin, C. R., and Parsons, E. M., Nature, 236, 385–390 (1972).
Black, J. W., Durant, G. J., Emmett, J. C., and Ganellin, C. R., Nature, 248, 65–67 (1974).
Chen, Y.-C., and Prusoff, W. H., Biochem. Pharmac., 22, 3099–3108 (1973).
Garbarg, M., Barbin, G., Feger, J., and Schwartz, J. -C., Science, 186, 833–835 (1974).
Joó, F., Rakonczay, Z., and Wollemann, M., Experientia, 31, 582–584 (1975).
Klein, I., and Levey, G. S., J. clin. Invest., 51, 1012–1015 (1971).
McNeill, J. H., and Verma, S. C., J. Pharmac. exp. Ther., 188, 180–188 (1974).
Domschke, W., Domschke, S., Classen, M., and Demling, L., Nature, 241, 454–455 (1973).
Dousa, T. P., and Code, C. F., J. clin. Invest., 53, 334–337 (1974).
Schultz, G., Hardman, J. G., Schultz, K., Baird, C. E., and Sutherland, E. W., Proc. natn. Acad. Sci. U.S.A., 70, 3889–3893 (1973).
Clyman, R. L., Sandler, J. A., Manganiello, V. C., and Vaughan, M., J. clin. Invest., 55, 1020–1025 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
HEGSTRAND, L., KANOF, P. & GREENGARD, P. Histamine-sensitive adenylate cyclase in mammalian brain. Nature 260, 163–165 (1976). https://doi.org/10.1038/260163a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/260163a0
This article is cited by
-
Histaminergic system in brain disorders: lessons from the translational approach and future perspectives
Annals of General Psychiatry (2014)
-
Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo
Psychopharmacology (2012)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.